Clinical Trials Reform Group Launches Study Monitoring Project
This article was originally published in The Gray Sheet
Executive Summary
The FDA/Duke University Clinical Trials Transformation Initiative is rolling out a detailed 1plan for its first project, aimed at defining best practices for clinical trial monitoring in various settings
You may also be interested in...
FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits - Guidance
Recent Duke University survey found that firms predominately conduct frequent visits to each clinical investigator site but "the rationale behind any specific monitoring approach does not appear to be evidence-based."
FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits – Guidance
Clinical trial sponsors should make greater use of off-site centralized monitoring, in place of frequent on-site visits, to ensure the quality of their trials, FDA emphasizes in new draft guidance.
FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits – Guidance
Clinical trial sponsors should make greater use of off-site centralized monitoring, in place of frequent on-site visits, to ensure the quality of their trials, FDA emphasizes in new draft guidance.